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Background: Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed neuropsychiatric disorder in
childhood, but the frequency of the condition is not well established in many countries. The aim of the present
study was to quantify the overall prevalence of ADHD among children and adolescents in Spain by means of a
systematic review and meta-analysis.
Methods: PubMed/MEDLINE, IME, IBECS and TESEO were comprehensively searched. Original reports were selected
if they provided data on prevalence estimates of ADHD among people under 18 years old in Spain and were cross-
sectional, observational epidemiological studies. Information from included studies was systematically extracted and
evaluated. Overall pooled-prevalence estimates of ADHD were calculated using random-effects models. Sources of
heterogeneity were explored by means sub-groups analyses and univariate meta-regressions.
Results: Fourteen epidemiological studies (13,026 subjects) were selected. The overall pooled-prevalence of ADHD
was estimated at 6.8% [95% confidence interval (CI) 4.9 – 8.8%] representing 361,580 (95% CI 260,550 – 467,927)
children and adolescents in the community. There was significant heterogeneity (P < 0.001), which was
incompletely explained by subgroup analyses and meta-regressions.
Conclusions: Our findings suggest that the prevalence of ADHD among children and adolescents in Spain is
consistent with previous studies conducted in other countries and regions. This study represents a first step in
estimating the national burden of ADHD that will be essential to building evidence-based programs and services.Background
Attention deficit hyperactivity disorder (ADHD) can be
defined as a condition starting in childhood, that com-
prises a persistent pattern of symptoms of hyperactivity,
impulsiveness and/or lack of attention, more frequent
and severe than usual for that age, and causing a signifi-
cant impairment in school or work performance and in
the activities of daily life. ADHD is a common neuro-
psychiatric disorder, with a high impact on the health
system and the community in terms of economic costs,* Correspondence: ferran_catala@hotmail.com
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distribution, and reproduction in any mediumfamily stress, academic and vocational adversity and a
clear negative effect on the self-esteem of the subject
affected [1].
Currently, there exist two diagnostic criteria in regular
use to diagnose ADHD in children and adolescents, DSM-
IV and ICD-10. Both classifications utilise lists of beha-
viours to consider in the process of diagnosing hyperactive
conditions. The main differences between DSM-IV and
ICD-10 pertain to the concomitance of the three domains
(inattention, hyperactivity and impulsivity), the exclusion
of comorbidity and the degree of pervasiveness. The ICD-
10 criteria require a full set of symptoms in all three
domains, whereas the DSM-IV recognizes three subtypes
of the disorder – the predominantly inattentive type, theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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bined type.
Despite its relevance in terms of public health, the fre-
quency of the disorder is not well established in many
countries, including Spain. This information may be ne-
cessary to improve the design of future studies on
aetiological factors and disease distribution in the popu-
lation, evaluate the effectiveness and cost-effectiveness
of various interventions or programmes and provide
representative reference values for evidence-based health
services planning. In recent decades, several observational
studies have been performed in different population
groups and geographic areas. Epidemiological studies in
several countries have used questionnaires and scales
based on symptoms as a criterion for ADHD. According
to previous studies, in Spain the prevalence of ADHD
would be 3-14% in children aged 8-15 years in Valencia
[2,3], 4-6% in children aged 6-15 years in Seville [4] and
1% in children aged 6-8 years in Navarre [5]. Therefore, it
would be relevant that the data provided in the scientific
literature were analysed through integrated approaches
which allow for establishing the extent of ADHD and its
epidemiological characteristics for the whole children and
adolescent population.
In this context, the objective of this study was to per-
form a systematic review of the studies performed in
Spain on the prevalence of ADHD in children and ado-




A systematic review was performed to document the
availability of prevalence data for ADHD among children
and adolescents in Spain. Methods were consistent with
those recommended by the Meta-analysis of Observa-
tional Studies in Epidemiology (MOOSE) group [6]. A
broad comprehensive search for original studies (pub-
lished between January 1980 and August 2011) was con-
ducted in the following electronic databases:
1. PubMed/MEDLINE (via the U.S. National Library of
Medicine): The following terms or keywords were
used: "attention deficit disorder with hyperactivity"
[MeSH Terms], ("attention" [All Fields] AND "deficit"
[All Fields] AND "disorder" [All Fields] AND
"hyperactivity" [All Fields]), "attention deficit disorder
with hyperactivity" [All Fields], "adhd" [All Fields],
"hyperkinesis" [MeSH Terms], combining them with
"epidemiologic studies" [MeSH], "prevalence" [MeSH
Terms] and with the geographic filtre proposed by
Valderas et al. [7] for identifying studies performed in
the Spanish population and minimizing bias
regarding the indexing of geographical items.2. Índice Médico Español (IME) and Índice Bibliográfico
Español en Ciencias de la Salud (IBECS): The
preferred terms “TDAH”, “trastorno por déficit de
atención”, “hiperactividad”, and “hipercinético” were
used.
3. TESEO database (database of Spanish PhD theses):
The preferred terms “TDAH”, “trastorno por déficit
de atención”, “hiperactividad”, and “trastorno
hipercinético” were used as descriptors.
The full list of terms used is shown in the Additional file 1:
"Search Terms Used in the Bibliographic Review". Further-
more, complementary hand-searches reviewing the litera-
ture of extracted articles were carried out.
Selection of studies
The primary end-point was the prevalence of ADHD
among children and adolescents. By design, we used the
investigator-reported definitions of ADHD patients pro-
vided in each single study. Of the references resulting after
the bibliographic review, those referring to original publi-
cations of epidemiological observational studies meeting
the following criteria were selected: cross-sectional design
and studies reporting data for current (point/past month)
or period prevalence of ADHD among people under 18
years old in Spain. For the purpose of the primary ana-
lyses, studies with any of the following criteria were
excluded: studies with samples selected in a clinical set-
ting, studies on adult population, lack of information on
relevant study issues (not specifying sample size, number
of cases, or the reference population), editorials and re-
view articles. No date (year of publication) or language
restrictions were established.
Data extraction
Information about design and participants were extracted
as recommended by PRISMA (Preferred Reporting Items
for Systematic Reviews and Meta-Analyses) guidelines [8].
The PRISMA and MOOSE checklists are provided in the
Web Appendix (Additional file 2: “PRISMA and MOOSE
checklists). Data extraction from source documents was
done independently by two investigators (one psychiatrist
and one epidemiologist) and verified. Disagreements were
resolved by consensus. The investigators used a specific
form specifically designed to extract data of methodo-
logical and scientific quality. The following variables were
collected: author and year of publication, author affiliation
(e.g. university, primary care, or hospital), journal title,
characteristics of the population (including sample size
and age), geographic area, origin of the sample (e.g. school
or population-based), some methodological issues (e.g.
diagnostic criteria, assessment tools and number of stages
of evaluation, clinical interview, impairment criterion
and source of information) and the main results. The
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subjects with ADHD) were obtained from the selected
studies. If these results were not directly provided and
it was feasible, they were calculated from the case and
population data provided in each single study.
Data analysis
The overall pooled-prevalence was estimated by random-
effects meta-analysis using the inverse variance method
[9,10]. Heterogeneity was evaluated using the Cochran’s
chi-squared test (Cochran’s Q) and the I2 statistics [11,12].
Cochran's Q is the sum of the squared differences between
each study's effect estimate and the overall effect estimate,
weighted for the information provided by the particular
study. I2 is the proportion of total variation observed
between the studies attributable to differences between
studies rather than sampling error. To investigate sources
of heterogeneity, subgroups (from the characteristics of
the population and study design) and univariate meta-
regression analyses were defined. Particularly, because the
large time span of the eligible studies, we explored trends
over time using random-effects meta-regression with the
year of publication as the explanatory variable. Similarly,
we explored trends of prevalence variation with gender
in terms of the male-to-female ratio. Because only a few
covariates were individually significant, multivariate meta-
regression or hierarchical models were not developed.
A sensitivity analysis was also conducted to examine
the possible influence of single studies by excluding
possible outlier (extreme) observations. The identifica-
tion of a study as an outlier was not based on an a
priori statistical criterion, but rather on visual evaluation
of forest plot with all selected studies. Furthermore, to345 articles retrieved from
48 full-text articles retrieved
16 articles (14 studies) includ
3 additional articles identified from 
reference lists and/or hand searching
13 articles (11 studies) eli
Figure 1 Flow diagram showing selection process of articles includedexplore investigator-reported definitions of ADHD across
the studies, we conducted sensitivity analyses to deter-
mine the robustness of effect size by excluding studies on
the basis of the clinical ascertainment (e.g. consider-
ation only of those studies including cases clinically
confirmed which applied DSM criteria and/or those
studies scoring above 1.5 standard deviation on differ-
ent specific questionnaires).
We assessed publication bias using the funnel plot
method.
All the analyses were performed using STATA 11
(StataCorp, College Station, TX, USA).
Results
Identification and selection of articles
Our initial searches yielded 345 literature references.
After screening titles and abstracts, 48 articles were po-
tentially eligible and were retrieved in full text. After a
careful reading of these articles, 11 studies were found
to meet the inclusion criteria. Complementary hand
searches allowed for identifying 3 additional studies.
Therefore, a total of 14 studies were included [2-5,13-24].
We excluded 35 reports (the reasons for exclusion are
given in Additional file 3: “List of Excluded References
and Reasons for Exclusion”). Figure 1 shows a flow dia-
gram for the selection process of studies included in
the systematic review.
Characteristics of the studies
The 14 studies included in the systematic review and in
the meta-analysis included a total of 13,026 children and
adolescents. Table 1 shows the summary characteristics
of the studies selected. The first author of most studies bibliographic search
297 excluded unlikely to be relevant 
based on title and abstract
 for detailed evaluation
35 articles excluded not meeting
one or more inclusion criteria
ed in systematic review
gible for final inclusion
in the systematic review.
Table 1 Summary characteristics of the 14 studies







Rev Neurol 3 (21.4)
Acta Psychiatr Scand 1 (7.1)
Soc Psychiatry Psychiatr Epidemiol 1 (7.1)
Rev Psiquiat y Psicol Med 1 (7.1)
An Psiquiatr 1 (7.1)
Actas Luso Esp Neurol Psiquiatr Cienc Afines 1 (7.1)
Acta Pediatr Esp 1 (7.1)
Rev Pediatr Aten Primaria 1 (7.1)
Arch Pediatr 1 (7.1)
Pediatr Catalana 1 (7.1)






Primary care 3 (21.4)
Hospital 2 (14.3)
Other/non explicit 2 (14.3)
Population age
Children and adolescents (under 17 years) 6 (42.9)
Children (under 12 years) 8 (57.1)
Origin of sample
School 11 (78.6)
General population 3 (21.4)
Reference to a diagnostic criterion
DSM-III-R 6 (42.9)
DSM-IV 4 (28.6)




Number of stages of evaluation
One 7 (50.0)
Two 7 (50.0)
Inclusion of clinical interview
Yes 8 (57.1)
No 6 (42.9)
Table 1 Summary characteristics of the 14 studies
included in the systematic review (Continued)
Source of information
Parents and teachers 9 (64.3)
Parents and subjects 2 (14.3)
Teachers 2 (14.3)
Parents, teachers and subjects 1 (7.1)
Catalá-López et al. BMC Psychiatry 2012, 12:168 Page 4 of 13
http://www.biomedcentral.com/1471-244X/12/168worked in an academic setting. With regard to the year
of publication, half of the studies were published in the
90s [2-4,13-15,22,23]. Only three of the studies were per-
formed in the general population [2,3,15,23] while in the
rest the sample of children and adolescents was obtained
from the school population [4,13,14,16-21]. Half of
the studies were described through a two-stage design
[2-4,15,16,18,20,22]: first, a psychometric screening
that evaluated the presence of ADHD symptoms in
children and adolescents; and second a clinical con-
firmation using standardised diagnostic criteria. The
specfic characteristics in each study included in the
systematic review are given in Table 2. Most of the
studies using diagnostic criteria [2-4,13-16,20-23] ap-
plied the DSM-III-R and/or DSM-IV criteria of the
American Psychiatric Association. In twelve studies
[2-5,13,16,18-21,23] the prevalence of ADHD was cal-
culated with information from at least 2 informers (in
nine of them from parents and teachers), while in two
studies [14,17] there was a single informer (the tea-
chers) to assess the presence of the disorder. The
fourteen studies provided the exact number of ADHD
cases in the study population and the relevant prevalence
rates, with values ranging from 1% to 14% [2,5,14]. Ten
studies reported the male-to-female ratio [3,13-17,19-24]
and the prevalence of ADHD was generally higher in
men than in women, with a 4:1 ratio in four studies
[14,17,22,24] and 2:1 in three studies [3,13,20].Overall meta-analysis and publication bias
The forest plot in Figure 2 shows the data from the single
studies and on the overall pooled-prevalence of ADHD
from the baseline meta-analysis. Using the random effect
model, an overall pooled-prevalence of ADHD of 6.8%
(95% CI 4.9 – 8.8%) was obtained for children and ado-
lescents with substantial between-study heterogeneity
(I2 = 95.9%; Q statistic P < 0.001). From the projections
of the current population [25] and the results of the
baseline meta-analysis, it was estimated that in Spain
ADHD would currently affect around 361,580 (95% CI
260,550 – 467,927) children and adolescents in the
community.
Visual inspection of the funnel plot denoted no evi-
dence of publication bias (Figure 3).

































Biscay Children 5-11.5 School
( N= 140 )
Hyperkinesia scales, perinatal history, neurological
examination and Bender-Gestalt test, CAT, Corman test,
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Asturias Children 6-11 School
( N= 1,048 )
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Castellon Children 10 General population
( N= 325 )
Conner’s scales, Werry-Weiss-Peters activity rating scale,
K-SADS-E, Raven's Colored Progressive Matrices, GAF
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non explicit
No 12.2%
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CAT: Children's Apperception Test; CBCL: Child Behavior Checklist; CSI: Child Symptom Inventory; GAF: Global Assessment of Functioning; K-SADS-E: Kiddy Schedule for affective diseases and Schizophrenia
(epidemiological version); PACS: Parenteral account of children's symptoms; PFT: Rosenzweig Picture Frustration Test; SDQ: Strengths and Difficulties Questionnaires; SNAP-IV: Swanson, Nolan y Pelham, 4th Edition;
VADTRS: Vanderbilt ADHD Teacher Rating Scale.; WISC: Wechsler Intelligence Scale for Children.



















Gómez-Beneyto et al, 1994 (8 years)
Andrés-Carrasco et al, 1995 and 1999
García-Jiménez et al, 2005
Blázquez-Almeria et al, 2005
Rodríguez-Molinero et al, 2009
Gutiérrez-Bengoechea, 1992
Gómez-Beneyto et al, 1994 (11 years)
Eddy, 1997
Author, year
Rodríguez-Hernández et al, 2006
Benjumea and Mojarro, 1993
Ruíz et al, 1999
Farré and Narbona, 1989
Cardo et al, 2007 and 2011
Verdeguer, 1994
Guimón et al, 1980






































Figure 2 Prevalence of ADHD among children and adolescents in Spain: meta-analysis. Note: Random effects model.
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Figure 3 Publication bias: funnel plot.
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Table 3 Prevalence of ADHD among children and adolescents in Spain: subgroup meta-analysis and heterogeneity analysis
Characteristics Observations* (N) Prevalence (%) 95% CI I2 P value
Origin of sample
School 11 6.7 4.2-9.1 97.0% < 0.001
General population 5 7.2 4.0-10.5 88.8% < 0.001
Geographic location
North/Northeast 8 7.6 3.8-11.4 97.9% < 0.001
South 2 4.6 3.5-5.7 38.4% 0.203
East 6 6.6 4.3-8.9 86.7% < 0.001
Sample size
< 600 subjects 9 6.1 3.7-8.4 91.9% < 0.001
> 600 subjects 7 7.7 5.0-10.4 96.4% < 0.001
Population age
Children (under 12 years) 10 7.0 4.1-9.9 96.0% < 0.001
Children and adolescent (under 17 years) 6 6.6 3.9-9.3 95.6% < 0.001
Peer reviewed journal
Yes 12 6.7 4.4-8.9 95.9% < 0.001
No 4 7.3 2.7-12.0 96.9% < 0.001
Reference to a diagnostic criterion
DSM-III-R 8 6.1 4.5-7.7 81.4% < 0.001
DSM-IV 3 9.9 4.6-15.2 94.8% < 0.001
None or not explicit 5 5.8 1.5-10.0 98.1% < 0.001
Impairment criterion
Yes 9 8.3 5.5-11.0 92.0% < 0.001
No 7 5.2 2.5-7.9 97.2% < 0.001
Clinical interview
Yes 9 6.4 4.9-7.9 82.2% < 0.001
No 7 7.0 3.0-10.9 98.1% < 0.001
Number of stages of evaluation
One 7 7.5 3.3-11.7 98.1% < 0.001
Two 9 6.0 4.6-7.4 82.8% < 0.001
Number of informants
One 2 13.0 11.1-14.9 65.0% 0.091
Two 13 5.5 4.1-6.9 90.7% < 0.001
Three 1 9.0 5.2-12.8 - -
Children are among the informants
Yes 5 7.6 4.1-11.2 89.4% < 0.001
No 11 6.5 4.1-8.9 97.0% < 0.001
Teachers are the sole informants
Yes 2 13.0 11.1-14.9 65.0% 0.091
No 14 5.7 4.3-7.1 90.4% < 0.001
*Note: Data set correspond to individual observations (n=16) because the study by Gómez-Beneyto contributed to analyses with three estimates (for people of 8,
11 and 15 year-old each).
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It must be noted that there was a high degree of hetero-
geneity between the studies included in the review in
terms of the prevalence calculated (Q = 367.8; P < 0.001).
Therefore, it was considered important to investigate and
try to explain the possible sources of heterogeneity that
could be present in the studies included in the review. For
this, subgroup analyses and univariate meta-regression
analyses were performed. Table 3 shows the results of the
meta-analysis by subgroups with the I2 indices. The
variables “geographic area” and “among informers only
teachers are included” would allow for explaining very
partially part of the heterogeneity found. The results of
random-effects meta-regression analyses that assessed
the relationship between selected covariates and the
observed prevalences in each single study is presented
in Figures 4 and 5. There was a non statistically signifi-
cant linear trend to explain effect size variation by year
of publication (P = 0.537). Similarly, there was a non
statistically significant linear trend to explain effect size
variation by gender in terms of the male-to-female ratio
(P = 0.557).
Sensitivity analyses
The results of the sensitivity analysis are provided in
Additional file 4: “Uncertainty and sensitivity analyses”).
The prevalence estimate after excluding the four estima-
tions with extreme outliers [2,5,15,23] was consistent


















Figure 4 Relationship between year of publication and the prevalenc
Meta-regression analysis. Note: The size of the bubble is inversely related to
regression (year of publication as the meta-independent variable). The shadprevalence of ADHD was 5.3% (95% CI 4.5 – 6.2%), with
moderate between-study heterogeneity (I2 = 60.8%; Q
statistic P = 0.003). Complementary sensitivity analyses
based on the clinical ascertainment (e.g. consideration
only studies including cases clinically confirmed by DSM
criteria) and the choice of the statistical model did not
make any noticeable difference for the above analyses
(please see webappendix, Additional file 4). Particularly,
in 7 out of 14 studies (6,175 children and adolescents)
with clinically confirmed ADHD cases, the pooled-
prevalence was 6.4% (95% CI 4.9 – 7.9%) with substan-
tial between-study heterogeneity (I2 = 82.2%; Q statistic
P < 0.001).
Discussion
This study reviewed 14 epidemiological observational
studies that analyse the prevalence of ADHD in children
and adolescents in Spain, over more than 13,000 people.
The main result was the identification of the epidemio-
logical information for providing an estimation of the
overall prevalence of disorder in the country. It also
provides a greater precision than that resulting of the
studies individually considered. Specifically, the results
of the meta-analysis show a pooled-prevalence of ADHD
of 6.8% in children and adolescents. These values would
be generally consistent with those found in the European
Union [26,27]. Wittchen et al. [27] recently estimated that
3.3 million children and adolescents aged 6-17 years have
ADHD in the European Union, with a prevalence of 5%.2000 2010
of publication
es of ADHD among children and adolescents in Spain.
the variance of the study. The solid line represents the linear




















0 2 4 6 8 10
Male -to-female ratio
Figure 5 Relationship between male-to-female ratio and the prevalences of ADHD among children and adolescents in Spain.
Meta-regression analysis. Note: The size of the bubble is inversely related to the variance of the study. The solid line represents the linear
regression (male-to-female ratio as the meta-independent variable). The shaded area corresponds to the confidence intervals of the prediction.
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yielded a world prevalence equivalent to 5.3%, with similar
values for developed regions.
ADHD is a major cause of personal impairment to
patients and their families and place a substantial burden
on the healthcare services [1]. Given the large amount of
literature on ADHD in recent years, healthcare profes-
sionals and decision-makers must have up-to-date epi-
demiological information gathering the best scientific
evidence that is useful for service planning and public
health policy. Particularly, this information may be ne-
cessary to improve the design of future nationwide
epidemiological studies, evaluate the impact of inter-
ventions or programmes on ADHD. With this regard,
the prevalence measures provided can be used to fur-
ther assess the non-fatal consequences of ADHD inte-
grating this information in summary measures of
population health, such as disability-adjusted life years
[28]. Furthermore, where scientific evidence exists on
the (cost-) effectiveness of particular health services and
treatments, our results can also provide data inputs neces-
sary for models of health impact assessments considering
the implementation of alternative interventions.
This study has some limitations that must be consid-
ered. On the one hand, it shows the generic limitations
of any systematic review and meta-analysis, particularly
that its quality depends on the studies included and that,
although the variability is controlled statistically by
random effect models, strata are weighed by theircharacteristics and heterogeneity is measured, it must
be always considered that the meta-analysis is a com-
bination of sometimes disagreeing results. With this
regard, the prevalence of ADHD ranged from 1% to
14% in the studies reviewed. Specifically, the study by
Farré and Narbona [5] reported the lowest frequencies
(1%). These values are probably influenced by the defin-
ition of a high critical score as hyperactivity index (> 18
of 30 points in the hyperactivity index of the Conners’
scales). In the same study, the authors recognised that,
considering subjects with a critical score in at least one
of the two questionnaires, the prevalence of ADHD was
6.4% (2.1% in parents, 3.4% in teachers and 0.8% both).
Furthermore, in two studies [14,17] using a single in-
former (the teacher) the prevalence rates were higher
(12-14%). This is consistent with the information from
other authors reporting that using two informers in-
stead of one usually provides a lower prevalence [26].
Along this, previous studies [29,30] found that teacher
and parents agreement on questionnaires is often low,
with teachers reporting more symptoms than parents.
Both the DSM-IV [31] and the ICD-10 criteria [32] re-
quire that the main symptoms (attention deficit, hyper-
activity and impulsiveness) occur in more than one
setting (e.g., home and school). For example, Rojo et al.
[33] analyzed the risk of ADHD characteristics among
obese adolescents using a self-administered report of
the Strengths and Difficulties Questionnaire (SDQ). As
they mentioned, the sensitivity for predicting ADHD
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were based only on data from one informant (adoles-
cents) and a clinical evaluation of the probable cases
was not conducted. Although the aim of that study was
not to establish prevalence estimates of ADHD, the
authors provided a proportion of ADHD characteristics
equals to 21.4% of adolescents aged 13-15 years. It is
noteworthy that these results diverge somewhat from
those obtained by Rodríguez-Hernández [18] and included
in our meta-analysis (3.9% of children aged 7-10 years
using parents/teachers’ SDQ).
As with other systematic reviews and meta-analyses
[26,34] a significant heterogeneity was found in the
prevalence measures, that were explained incompletely
by analysis of subgroups and univariate meta-regressions.
In our study, the variables “geographic area” (e.g. South
region), “among informers only teachers are included”
and/or “one informant” would allow for explaining very
partially part of the heterogeneity found. Meta-regression
on all epidemiological studies showed only a non statisti-
cally linear trend to explain effect variation by year of pub-
lication and male-to-female ratio, perhaps because of the
limited power of our analysis (e.g. number of observa-
tions). These findings also suggest that other unknown
factors could be important in accounting for between-
study variations. For example, it is noteworthy that none
of the studies included in our systematic review has stud-
ied the overall prevalence within the national population.
The lack of whole population studies has been criticised
in the past because selected populations (e.g. subnational/
local different samples) and settings (e.g. population-based
versus school-based studies) might introduce bias and
some degree of uncertainty to the estimates. Previously,
the revision by Skounti et al. [34] suggested that the
characteristics of the population, the study methods
and the diagnostic criterion differences could explain
part of the changes in the ADHD prevalence rates.
The existence of nonindexed epidemiological studies
in the databases consulted may have involved the loss of
some locally relevant studies despite the extensive
data searches we made (e.g. PubMed/MEDLINE, IME,
IBECS and TESEO). Although an attempt was made
to minimize this possible screening bias with specific
searches in national databases and thesis dissertations,
there may be other studies which have not been iden-
tified. However, publication bias is not anticipated (as
denoted by funnel plot) because of we obtained a sub-
stantial proportion of data from unpublished studies.
We also conducted subgroup and sensitivity analyses
to assess uncertainty assumptions on the pooled
ADHD-prevalence for study characteristics. Such an
approach is important in assessing the validity of the
assumptions made for the statistical calculations in meta-
analyses. Unfortunately information on methodologicalquality of selected studies was insufficient to allow a
detailed analysis of their quality.
The diagnosis of ADHD is complex and should be
based on the clinical assessment confirmed by an expert
on the recognition and treatment of it. In epidemio-
logical studies there is no agreement about the instru-
ments to be used for evaluating children with potential
ADHD; there is also some controversy about the criteria
to be used for defining a so-called “case”. These difficul-
ties in the detection, diagnostic process and methods
affect the epidemiological studies performed, originating
changes that can lead to under- or over-diagnosing
ADHD. In our meta-analysis, although based on a small
subgroup of studies, the inclusion of those epidemiological
studies that were restricted to clinically confirmed ADHD
cases (e.g. DSM diagnostic criteria) led to a reduction of
the pooled-prevalence from 6.8% (95% CI 4.9 – 8.8%) to
6.4% (95% CI 4.9 – 7.9%), which is even more consistent
with the prevalence rates worldwide [26]. Similarly, people
who screen negative do not undergo the clinical ascertain-
ment by the specialists, therefore false negatives might
have occurred in some epidemiological studies. In this
revision, a number of studies did not mention any
reference diagnostic criterion [5,17,18,24]. In addition,
some used only screening scales with a low sensitivity
and specificity and that are not valid as a single meas-
urement for the diagnosis. Actually, DSM-IV and ICD-
10 are the diagnostic criteria most commonly used.
Both classifications describe the clinical condition of
hyperactive children (ADHD/Hyperkinetic disorder) and
use similar operative criteria for diagnosing it. However, as
the ICD-10 diagnostic criteria are more restrictive, the
diagnoses according to this classification will correspond
to the most severe cases of ADHD according to DSM-IV
criteria. Therefore, the prevalence studies taking ICD-10
as reference will probably yield lower rates than those
using DSM-IV. ICD-10 and DSM-IV are also different
when considering the subtypes of disorder.
The disagreement between the different studies in
terms of case definition criteria involves the need for
performing separate analyses for each criteria used for
the diagnosis of ADHD. In our revision, no study
reported expressly ICD-10 reference diagnoses. There
exist evidences [35-37] that the prevalence of ADHD as
defined in the DSM-IV can be somewhat higher than
when defined according to DSM-III-R criteria, due to
the inclusion of the types “with hyperactive-impulsive
predominance” and “with attention deficit predomin-
ance” (that had been diagnosed as ADHD not specified
in the DSM-III-R) [38]. For the diagnosis of ADHD, the
DSM-III-R requires the presence of at least 8 symptoms
of a total of 14; it does not include the requirement that
they must occur in at least two settings and does not
give a division into subtypes, and the severity criterion is
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meta-analysis, we confirmed that the use of DSM-IV vs
DSM-III-R increases the prevalence rate. However, it is
note worthy that the analyses of subgroups involve a loss
of statistical power and, therefore, of precision and the
unfeasibility to analyse population subgroups that would
have been interesting (e.g. analysis by age or social class).
As with other revisions [26,34] in virtually all the studies
reviewed, regardless of the methods used, the prevalence
rates of ADHD were significantly higher in men than in
women. On the contrary, in the study by Cardo et al.
[19] ADHD prevalence rates were slightly higher among
women. This could be due to the fact that retained stu-
dents, children with special educational needs and those
with some known psychopathological diagnosis were
excluded from the study, which would have underesti-
mated prevalence in males.Conclusion
The prevalence of ADHD based on evidence synthesis
techniques (systematic reviews and metanalysis) are
readily calculated and useful for measuring the fre-
quency of the disorder for a specific country. Particu-
larly, our findings suggest that the prevalence of ADHD
among children and adolescents is considerable in Spain.
Our estimates are consistent with those previously
reported in other countries and regions. Finally, this
study also represents a first step in estimating the na-
tional burden of ADHD that will be essential to building
evidence-based programs and services.Additional files
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